Anti-TNC-C polyclonal antibody
Invented by Tambet Teesalu , Prakash Lingasamy
Invented at University of Tartu
- References (1)
- Inventor Info
|Applications||ELISA IHC IF|
|Antigen/Gene or Protein Targets||Tenascin-C C-domain|
Oncofetal fibronectin (FN-EDB) and tenascin-C C domain (TNC-C) are nearly absent in extracellular matrix of normal adult tissues but upregulated in malignant tissues. Both FN-EDB and TNC-C are developed as targets of antibody-based therapies.
This series of antibodies has been validated in vitro against glioblastoma (GBM) and prostate carcinoma xenografts, and to non-malignant angiogenic neovessels induced by VEGF-overexpression.
Please see our related anti-FN-EDB antibodies from University of Tartu.
There are 1 reference entries for this reagent.View All References